Spencer Lee Sells 1,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 1,000 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the transaction, the executive vice president owned 13,912 shares in the company, valued at $7,526,948.48. The trade was a 6.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Chemed Stock Up 0.4%

Shares of NYSE CHE opened at $543.56 on Wednesday. The stock has a market cap of $7.10 billion, a PE ratio of 27.30, a P/E/G ratio of 2.05 and a beta of 0.51. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The company has a 50-day moving average of $503.79 and a 200 day moving average of $447.97.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business’s revenue was up 8.8% on a year-over-year basis. During the same period last year, the company posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, sell-side analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be issued a $0.70 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. Chemed’s payout ratio is 14.06%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP acquired a new position in Chemed in the 2nd quarter valued at about $1,726,000. TD Asset Management Inc lifted its position in shares of Chemed by 7.5% during the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after purchasing an additional 22,715 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of Chemed by 14.5% during the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after purchasing an additional 4,430 shares in the last quarter. Epoch Investment Partners Inc. lifted its position in shares of Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock worth $137,945,000 after purchasing an additional 15,133 shares in the last quarter. Finally, Abacus FCF Advisors LLC purchased a new position in shares of Chemed in the fourth quarter valued at approximately $5,935,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on CHE shares. Royal Bank Of Canada boosted their price objective on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Oppenheimer raised their target price on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Chemed has a consensus rating of “Hold” and a consensus price target of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.